Cypermethrin induces astrocyte apoptosis by the disruption of the autocrine/paracrine mode of epidermal growth actor receptor signaling

Toxicological Sciences

Volumn 125, Issue 2, 2012, Pages 473-487

  Maurya, Shailendra Kumar ^a   Rai, Asit ^a   Rai, Nagendra Kumar ^a   Deshpande, Shreekant ^b   Jain, Rajeev ^a   Mudiam, Mohana Krishna Reddy ^a   Prabhakar, Yenamandra S ^b   Bandyopadhyay, Sanghamitra ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Autocrine paracrine; MAPK; Mitochondria; Phosphorylation

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CASPASE 3; CASPASE 7; CASPASE 9; CIPERMETHRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; AUTOCRINE EFFECT; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; EVOLUTIONARY HOMOLOGY; MITOCHONDRION; MOLECULAR DOCKING; NONHUMAN; PARACRINE SIGNALING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84856084736     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr303     Document Type: Article

References (63)

1. Ayuso-Sacido, A., Moliterno, J. A., Kratovac, S., Kapoor, G. S., O'Rourke, D. M., Holland, E. C., Garci{dotless}́a-Verdugo, J. M., Roy, N. S., and Boockvar, J. A. (2010). Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells. J. Neurooncol. 97, 323-337.
2. Bandyopadhyay, S., Hartley, D. M., Cahill, C. M., Lahiri, D. K., Chattopadhyay, N., and Rogers, J. T. (2006). Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase. J. Neurosci. Res. 84, 106-118.
3. Burrows, R. C., Wancio, D., Levitt, P., and Lillien, L. (1997). Response diversity and the timing of progenitor cell maturation are regulated by developmental changes in EGFR expression in the cortex. Neuron 19, 251-267.
4. Calvert, G. M., Mehler, L. N., Rosales, R., Baum, L., Thomsen, C., Male, D., Shafey, O., Das, R., Lackovic, M., and Arvizu, E. (2003). Acute pesticide related illnesses among working youths, 1988-1999. Am. J. Public Health 93, 605-610.
5. Casco, V. H., Izaguirre, M. F., Marin, L., Vergara, M. N., Lajmanovich, R. C., Peltzer, P., and Soler, A. P. (2006). Apoptotic cell death in the central nervous system of Bufo arenarum tadpoles induced by cypermethrin. Cell Biol. Toxicol. 22, 199-211.
6. Casida, J. E., and Quistad, G. B. (1998). Golden age of insecticide research: Past, present, or future? Annu. Rev. Entomol. 43, 1-16.
7. Choi, S., Choi, Y., Dat, N. T., Hwangbo, C., Lee, J. J., and Lee, J. H. (2010). Tephrosin induces internalization and degradation of EGFR and ErbB2 in HT-29 human colon cancer cells. Cancer Lett. 293, 23-30.
8. Costa, L. G., Giordano, G., Guizzetti, M., and Vitalone, A. (2008). Neurotoxicity of pesticides: A brief review. Front. Biosci. 13, 1240-1249.
9. Davis, J. W., II, Lauer, F. T., Burdick, A. D., Hudson, L. G., and Burchiel, S. W. (2001). Prevention of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-10A cell line: Correlation with increased transforming growth factor alpha production. Cancer Res. 61, 3314-3320.
10. Du, T., Li, B., Liu, S., Zang, P., Prevot, V., Hertz, L., and Peng, L. (2009). ERK phosphorylation in intact, adult brain by alpha(2)-adrenergic transactivation of EGF receptors. Neurochem. Int. 55, 593-600.
11. Eriksson, P., and Fredricksson, A. (1991). A neurotoxic effect of two different pyrethroids, bioallethrin and deltamethrin on immature and adult mice. Toxicol. Appl. Pharmacol. 108, 78-85.
12. Farkas, L. M., and Krieglstein, K. (2002). Heparin-binding epidermal growth factor-like growth factor (HB-EGF) regulates survival of midbrain dopaminergic neurons. J. Neural. Transm. 109, 267-277.
13. Ferrer, I., Alcantara, S., Ballabriga, J., Olive, M., Blanco, R., Rivera, R., Carmona, M., Berruezo, M., Pitarch, S., and Planas, A. M. (1996). Transforming growth factor-alpha (TGF-alpha) and epidermal growth factor-receptor (EGF-R) immunoreactivity in normal and pathologic brain. Prog. Neurobiol. 49, 99-123.
14. Grimm, I., Messemer, N., Stanke, M., Gachet, C., and Zimmermann, H. (2009). Coordinate pathways for nucleotide and EGF signaling in cultured adult neural progenitor cells. J. Cell Sci. 122, 2524-2533.
15. Gu, L., Li, B., Yang, X., Hu, X., Huang, X., Hertz, L., and Peng, L. (2007). Depolarization-induced, glutamate receptor-mediated, and transactivationdependent extracellular-signal regulated kinase phosphorylation in cultured cerebellar granule neurons. Neuroscience 147, 342-353.
16. Gupta, A., Agarwal, R., and Shukla, G. S. (1999). Functional impairment of blood-brain barrier following pesticide exposure during early development in rats. Hum. Exp. Toxicol. 18, 174-179.
17. Gupta, A., Agarwal, A. K., and Shukla, G. S. (2000). Effect of quinalphos and cypermethrin exposure on developing blood-brain barrier: Role of nitric oxide. Environ. Toxicol. Pharmacol. 8, 73-78.
18. Heudorf, U., Angerer, J., and Drexler, H. (2004). Current internal exposure to pesticides in children and adolescents in Germany: Urinary levels of metabolites of pyrethroid and organophosphorus insecticides. Int. Arch. Occup. Environ. Health 77, 67-72.
19. Iwamoto, R., Yamazaki, S., Asakura, M., Takashima, S., Hasuwa, H., Miyado, K., Adachi, S., Kitakaze, M., Hashimoto, K., Raab, G., et al. (2003). Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl. Acad. Sci. U.S.A. 100, 3221-3226.
20. Jin, K., Mao, X. O., Del Rio Guerra, G., Jin, L., and Greenberg, D. A. (2005). Heparin-binding epidermal growth factor-like growth factor stimulates cell proliferation in cerebral cortical cultures through phosphatidylinositol 3'-kinase and mitogen-activated protein kinase. J. Neurosci. Res. 81, 497-505.
21. Jin, K., Mao, X. O., Sun, Y., Xie, L., Jin, L., Nishi, E., Klagsbrun, M., and Greenberg, D. A. (2002). Heparin-binding epidermal growth factor-like growth factor: Hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo. J. Neurosci. 22, 5365-5373.
22. Jin, K., Sun, Y., Xie, L., Childs, J., Mao, X. O., and Greenberg, D. A. (2004). Post-ischemic administration of heparin-binding epidermal growth factor-like growth factor (HB-EGF) reduces infarct size and modifies neurogenesis after focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 24, 399-408.
23. Jin, Y., Zheng, S., Pu, Y., Shu, L., Sun, L., Liu, W., and Fu, Z. (2011). Cypermethrin has the potential to induce hepatic oxidative stress, DNA damage and apoptosis in adult zebrafish (Danio rerio). Chemosphere 82, 398-404.
24. Kim, I., Crippen, G. M., and Amidon, G. L. (2004). Structure and specificity of a human valacyclovir activating enzyme: A homology model of BPHL. Mol. Pharm. 1, 434-446.
25. Kimata, A., Kondo, T., Ueyama, J., Yamamoto, K., Yoshitake, J., Takagi, K., Suzuki, K., Inoue, T., Ito, Y., Hamajima, N., et al. (2009). Comparison of urinary concentrations of 3-phenoxybenzoic acid among general residents in rural and suburban areas and employees of pest control firms. Int. Arch. Occup. Environ. Health 82, 1173-1178.
26. Kornblum, H. I., Hussain, R., Wiesen, J., Miettinen, P., Zurcher, S. D., Chow, K., Derynck, R., and Werb, Z. (1998). Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor. J. Neurosci. Res. 53, 697-717.
27. Kornblum, H. I., Zurcher, S. D., Werb, Z., Derynck, R., and Seroogy, K. B. (1999). Multiple trophic actions of heparin-binding epidermal growth factor (HB-EGF) in the central nervous system. Eur. J. Neurosci. 11, 3236-3246.
28. Kwon, K. J., Cho, K. S., Lee, S. H., Kim, J. N., Joo, S. H., Ryu, J. H., Ignarro, L. J., Han, S. H., and Shin, C. Y. (2011). Regulation of tissue plasminogen activator/plasminogen activator inhibitor-1 by hydrocortisone in rat primary astrocytes. J. Neurosci. Res. 89, 1059-1069.
29. Leach, R. E., Kilburn, B. A., Petkova, A., Romero, R., and Armant, D. R. (2008). Diminished survival of human cytotrophoblast cells exposed to hypoxia/reoxygenation injury and associated reduction of heparin-binding epidermal growth factor-like growth factor. Am. J. Obstet. Gynecol. 198, 471 e1- 7; discussion 471 e7-8.
30. Lee, D. C., Fenton, S. E., Berkowitz, E. A., and Hissong, M. A. (1995). Transforming growth factor alpha: Expression, regulation, and biological activities. Pharmacol. Rev. 47, 51-85.
31. Levitzki, A., and Gazit, A. (1995). Tyrosine kinase inhibition: An approach to drug development. Science 267, 1782-1788.
32. Liu, B., Chen, H., Johns, T. G., and Neufeld, A. H. (2006). Epidermal growth factor receptor activation: An upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury. J. Neurosci. 26, 7532-7540.
33. Liu, B., and Neufeld, A. H. (2007). Activation of epidermal growth factor receptors in astrocytes: From development to neural injury. J. Neurosci. Res. 85, 3523-3529.
34. Lo, H. W., Hsu, S. C., and Hung, M. C. (2006). EGFR signaling pathway in breast cancers: From traditional signal transduction to direct nuclear translocalization. Breast Cancer Res. Treat. 95, 211-218.
35. Luo, C. C., Ming, Y. C., Chao, H. C., Chu, S. M., and Pang, S. T. (2010). Heparin-binding epidermal growth factor-like growth factor downregulates expression of activator protein-1 transcription factor after intestinal ischemiareperfusion injury. Neonatology 99, 241-246.
36. Ma, Y. J., Berg-von der Emde, K., Moholt-Siebert, M., Hill, D. F., and Ojeda, S. R. (1994). Region-specific regulation of transforming growth factor alpha (TGF alpha) gene expression in astrocytes of the neuroendocrine brain. J. Neurosci. 14, 5644-5651.
37. Malkiewicz, K., Koteras, M., Folkesson, R., Brzezinski, J., Winblad, B., Szutowski, M., and Benedikz, E. (2006). Cypermethrin alters glial fibrillary acidic protein levels in the rat brain. Environ. Toxicol. Pharmacol. 21, 51-55.
38. Marikovsky, M., Breuing, K., Liu, P. Y., Eriksson, E., Higashiyama, S., Farber, P., Abraham, J., and Klagsbrun, M. (1993). Appearance of heparinbinding EGF-like growth factor in wound fluid as a response to injury. Proc. Natl. Acad. Sci. U.S.A. 90, 3889-3893.
39. Mense, S. M., Sengupta, A., Lan, C., Zhou, M., Bentsman, G., Volsky, D. J., Whyatt, R. M., Perera, F. P., and Zhang, L. (2006). The common insecticides cyfluthrin and chlorpyrifos alter the expression of a subset of genes with diverse functions in primary human astrocytes. Toxicol. Sci. 93, 125-135.
40. Miller, M. W., and Robertson, S. (1993). Prenatal exposure to ethanol alters the postnatal development and transformation of radial glia to astrocytes in the cortex. J. Comp. Neurol. 37, 837253-837266.
41. Mishima, K., Higashiyama, S., Asai, A., Yamaoka, K., Nagashima, Y., Taniguchi, N., Kitanaka, C., Kirino, T., and Kuchino, Y. (1998). Heparinbinding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas. Acta Neuropathol. 96, 322-328.
42. Nakagawa, T., Sasahara, M., Hayase, Y., Haneda, M., Yasuda, H., Kikkawa, R., Higashiyama, S., and Hazama, F. (1998). Neuronal and glial expression of heparin-binding EGF-like growth factor in central nervous system of prenatal and early-postnatal rat. Brain Res. Dev. Brain Res. 108, 263-272.
43. Nasuti, C., Rosita, G., Falcioni, M. L., Di Stefano, A., Sozio, P., and Cantalamessa, F. (2007). Dopaminergic system modulation, behavioral changes, and oxidative stress after neonatal administration of pyrethroids. Toxicology 229, 194-205.
44. Niederer, K. E., Morrow, D. K., Gettings, J. L., Irick, M., Krawiecki, A., and Brewster, J. L. (2005). Cypermethrin blocks a mitochondria-dependent apoptotic signal initiated by deficient N-linked glycosylation within the endoplasmic reticulum. Cell. Signal. 17, 177-186.
45. Newmeyer, D. D., and Ferguson-Miller, S. (2003). Mitochondria: Releasing power for life and unleashing the machineries of death. Cell 112, 481-490.
46. Opanashuk, L. A., Mark, R. J., Porter, J., Damm, D., Mattson, M. P., and Seroogy, K. B. (1999). Heparin-binding epidermal growth factor-like growth factor in hippocampus: Modulation of expression by seizures and anti-excitotoxic action. J. Neurosci. 19, 133-146.
47. Peng, L., Li, B., Du, T., Kong, E. K., Hu, X., Zhang, S., Shan, X., and Zhang, M. (2010). Astrocytic transactivation by alpha2A-adrenergic and 5-HT2B serotonergic signaling. Neurochem. Int. 57, 421-431.
48. Power, L. E., and Sudakin, D. L. (2007). Pyrethrin and pyrethroid exposures in the United States: A longitudinal analysis of incidents reported to poison centers. J. Med. Toxicol. 3, 94-99.
49. Rai, A., Maurya, S. K., Khare, P., Srivastava, S., and Bandyopadhyay, S. (2010). Characterization of developmental neurotoxicity of As, Cd and Pb mixture: Synergistic action of metal mixture in glial and neuronal functions. Toxicol. Sci. 118, 586-601.
50. Ramnarain, D. B., Park, S., Lee, D. Y., Hatanpaa, K. J., Scoggin, S. O., Out, H., Libermann, T. A., Raisanen, J. M., Ashfaq, R., Wong, E. T., et al. (2006). Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells. Cancer Res. 66, 867-874.
51. Reers, M., Smiley, S. T., Mottola-Hartshorn, C., Chen, A., Lin, M., and Chen, L. B. (1995). Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol. 260, 406-417.
52. Rocks, N., Estrella, C., Paulissen, G., Quesada-Calvo, F., Gilles, C., Gueders, M. M., Crahay, C., Foidart, J. M., Gosset, P., Noel, A., et al. (2008). The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis. Cell Prolif. 41, 988-1001.
53. Shafer, T. J., and Meyer, D. A. (2004). Effects of pyrethroids on voltagesensitive calcium channels: A critical evaluation of strengths, weaknesses, data needs, and relationship to assessment of cumulative neurotoxicity. Toxicol. Appl. Pharmacol. 196, 303-318.
54. Shettgen, T., Heudorf, U., Drexler, H., and Angerer, J. (2002). Pyrethroid exposure of the general population-Is this due to diet. Toxicol. Lett. 134, 141-145.
55. Shim, Y. J., Shin, Y. J., Jeong, S. Y., Kang, S. W., Kim, B. M., Park, I. S., and Min, B. H. (2009). Epidermal growth factor receptor is involved in clusterin-induced astrocyte proliferation. Neuroreport 20, 435-439.
56. Sibilia, M., Steinbach, J. P., Stingl, L., Aguzzi, A., and Wagner, E. F. (1998). A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. EMBO J. 17, 719-731.
57. Singh, P., Lata, P., Patel, S., Pandey, A. K., Jain, S. K., Shanker, R., and Dhawan, A. (2011). Expression profiling of toxicity pathway genes by real-time PCR array in cypermethrin-exposed mouse brain. Toxicol. Mech. Methods 21, 193-199.
58. Sinha, R. A., Khare, P., Rai, A., Maurya, S. K., Pathak, A., Mohan, V., Nagar, G. K., Mudiam, M. K., Godbole, M. M., and Bandyopadhyay, S. (2009). Anti-apoptotic role of omega-3-fatty acids in developing brain: Perinatal hypothyroid rat cerebellum as apoptotic model. Int. J. Dev. Neurosci. 27, 377-383.
59. Stamos, J., Sliwkowski, M. X., and Eigenbrot, C. (2002). Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 277, 46265-46272.
60. Tanaka, N., Sasahara, M., Ohno, M., Higashiyama, S., Hayase, Y., and Shimada, M. (1999). Heparin-binding epidermal growth factor-like growth factor mRNA expression in neonatal rat brain with hypoxic/ischemic injury. Brain Res. 827, 130-138.
61. Ward, W. H., Cook, P. N., Slater, A. M., Davies, D. H., Holdgate, G. A., and Green, L. R. (1994). Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor. Biochem. Pharmacol. 48, 659-666.
62. Wiedmann, M. W., and Mössner, J. (2011). Molecular targeted therapy of hepatocellular carcinoma-Results of the first clinical studies. Curr. Cancer Drug Targets 11, 714-733.
63. Yamaguchi, H., and Wang, H. G. (2001). The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 20, 7779-7786.